Onderneming Lineage Cell Therapeutics, Inc.
Aandelen
LCTX
US53566P1093
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,06 USD | +0,95% | -7,02% | -2,75% |
Vakgebied
Aantal werknemers: 72
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutic Products
100,0
%
| 15 | 100,0 % | 9 | 100,0 % | -39,16% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 15 | 100,0 % | 9 | 100,0 % | -39,16% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 17-09-18 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 14-11-22 |
Chief Operating Officer | - | 01-01-10 | |
Gary S. Hogge
CTO | Chief Tech/Sci/R&D Officer | 56 | 01-02-18 |
Ioana C. Hone
IRC | Investor Relations Contact | - | - |
George Samuel
LAW | General Counsel | 43 | 01-09-21 |
Derek Kelaita
PRN | Corporate Officer/Principal | - | 01-08-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 01-07-09 |
Brian Culley
CEO | Chief Executive Officer | 53 | 17-09-18 |
Director/Board Member | 66 | 11-04-14 | |
Don Bailey
BRD | Director/Board Member | 78 | 01-03-20 |
Angus Russell
BRD | Director/Board Member | 68 | 09-12-14 |
Michael Mulroy
CHM | Chairman | 58 | 04-10-14 |
Director/Board Member | 67 | 04-05-21 | |
Dipti Amin
BRD | Director/Board Member | 60 | 20-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 188 798 145 | 187 985 347 ( 99,57 %) | 0 | 99,57 % |
Bedrijfsgegevens
Lineage Cell Therapeutics, Inc.
2173 Salk Avenue Suite 200
92008-7354, Carlsbad
+442 287 8990
http://www.lineagecell.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,75% | 200 mln. | |
+25,69% | 47,86 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,66 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |
- Beurs
- Aandelen
- Koers LCTX
- Onderneming Lineage Cell Therapeutics, Inc.